Clinical Trials Logo

Clinical Trial Summary

Emotional overeating is characterized by an excessive food intake in the context of intense emotional situations, such as acute stress one. Emotional overeating, as a behavioral trait, can increase the risk of to develop eating disorders or eating-related diseases, such as metabolic syndrome, obesity, type-2 diabetes. Recently, imaging modalities, such as magnetic resonance imaging (MRI) and electro-encephalography (EEG), have been adapted in order to perform neurofeedback consisting on presenting the brain activity instantaneously to the participant, that give him the possibility to modify this activity by his own mean. Neurofeedback has already shown some efficacy, either with explicit or implicit instruction. Compared with functional MRI (fMRI), functional near infra-red spectroscopy (fNIRS) is easy to handle, less expensive, and does not require a lying position. fNIRS is consequently more adapted for repeated acquisitions. Neurofeedback has already shown some promising results for neurological and psychiatric diseases. For mental states and emotion regulation, neurofeedback targeting the prefrontal cortex (PFC) has also shown promising outcomes. In this project, the investigators want to assess the effect of neurofeedback targeting the dorsolateral PFC (dlPFC) in a population of young adult women presenting emotional overeating. The investigators aim to improve the cognitive control and to reduce the episodes of emotional overeating in order to prevent the occurrence of subsequent pathologies. The intervention effect will be characterized with: (i) fMRI in order to evaluate the effect on cognitive control (with resting state fMRI or rsMRI) and on the reward system; (II) questionaries directly and one month after intervention in order to assess the behavioral effect. Besides an expected effect on emotional overeating, the investigators will evaluate whether an improvement of cognitive control can also promote positive effect on other behavioral traits that could lead to some pathologies such as food addiction. As a prerequisite to this study on emotional overeating (study B), the investigators will firstly validate on healthy subjects (study A) a reward anticipation fMRI task, which will be further used in study A in order to characterized the effect of neurofeedback on the reward system.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05200182
Study type Interventional
Source Rennes University Hospital
Contact Loïc JACOB
Phone 0299282555
Email loic.jacob@chu-rennes.fr
Status Recruiting
Phase N/A
Start date April 7, 2022
Completion date May 2025

See also
  Status Clinical Trial Phase
Completed NCT02629991 - Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome Phase 2
Recruiting NCT05939453 - Impact of Bright Light Therapy on Prader-Willi Syndrome N/A
Terminated NCT03790865 - Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome Phase 2/Phase 3
Completed NCT03375853 - Computerized Response Training Obesity Treatment N/A
Completed NCT04150991 - Fiber Intervention on Gut Microbiota in Children With Prader-Willi Syndrome N/A
Recruiting NCT06239064 - Early Genetic Identification of Obesity
Recruiting NCT05044000 - Effect of Deep Propioceptive Stimulation in Prader-Willi Syndrome N/A
Terminated NCT00175305 - Prader-Willi Syndrome and Appetite Phase 3
Recruiting NCT02758262 - Effects of Noninvasive Brain Stimulation on Brain Activity and Appetite N/A
Completed NCT01863017 - Pilot Study of Startle-response Test to Assess Transcranial Direct Current Stimulation-induced Modulation of Hyperphagia in Prader-Willi Syndrome N/A
Recruiting NCT03197662 - Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome Phase 2